CI News and Press, Cigna Corporation From 05/29/23

2023-05-29 12:07:01 ET Summary Cigna is growing rapidly and earnings per share have increased 13% annually over the past 4 years. The long-term outlook is also positive: Cigna is targeting annual EPS growth between 10% and 13%. About 20% of cash flow from operations is spent o...

2023-05-22 23:15:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

The Cigna Group and Connecticut Governor Lamont Celebrate Freedom Team Athletes During 2023 Achilles International Relay PR Newswire Gov. Lamont, Cigna CEO David Cordani honored the team's wounded military personnel and veterans at the State Capitol during the Connecti...

2023-05-22 05:00:00 ET Summary Pharmaceuticals/biotechnology and healthcare providers still have good value scores. Healthcare equipment is the less attractive subsector. Fast facts on IHF, a healthcare providers ETF. 10 stocks cheaper than their peers in May. ...

2023-05-17 13:49:04 ET CVS Health Corporation ( NYSE: CVS ) has agreed to pay $6.1M to resolve allegations that the pharmacy chain did not comply with the prescription drug pricing rules related to Massachusetts' workers' compensation insurance program. The deal identified sever...

AM Best has upgraded most of the Long-Term Issuer Credit Ratings (Long-Term ICRs) to “a+” (Excellent) from “a” (Excellent) and affirmed the Financial Strength Rating (FSR) of A (Excellent) of the key U.S. life/health subsidiaries, health maintenance organizations and...

2023-05-12 13:41:59 ET Summary CVS is undervalued and generates impressive cash flow, but it faces competition, regulatory challenges, and low operating margins, resulting in mediocre returns on capital. Before investing, I believe an investor should study the complex operations b...

2023-05-10 17:47:30 ET Eli Lilly ( NYSE: LLY ) CEO David Ricks on Thursday told a Senate committee that his company won't boost the prices of any of its insulin medicines currently on the market. Ricks made the comments before the Senate Health, Education, Labor & Pensions c...

2023-05-09 20:42:32 ET Summary Davis Selected Advisers 13F portfolio value increased from $14.71B to $15.13B this quarter. They increased Amazon and JD.com while reducing Quest Diagnostics. The top three positions are Meta Platforms, Berkshire Hathaway, and Wells Fargo, and th...

2023-05-06 09:00:00 ET Summary This article is part of our monthly series where we highlight five companies that are large-cap, relatively safe, dividend-paying and are offering large discounts to their historical norms. We go over our filtering process to select just five conserv...